Tandem Diabetes Care Inc
(LTS:0M0F)
$
32.8
-0.13 (-0.39%)
Market Cap: 2.17 Bil
Enterprise Value: 2.19 Bil
PE Ratio: 0
PB Ratio: 9.19
GF Score: 76/100 Tandem Diabetes Care Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2021 / 05:10PM GMT
Release Date Price:
$135.47
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst
© -
Well, listen, thanks, everybody, for joining us. We're very pleased to have with again Tandem Diabetes. John Sheridan, President and CEO; Leigh Vosseller, Executive Vice President and CFO. My name is Matt Miksic, I cover medical supplies and devices at Credit Suisse. And as I mentioned, we're pleased to be able to host you again this year. Thanks for coming.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
Absolutely. Good to see you.
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst
© -
And so I thought it might be helpful to start with -- as some people may know. And I think if we look at the chart on the stock to see is that strangely, you had a very strong Q3. And -- but the stock has responded due to some comments that you made on the call. And so I'd say -- I'm imagining you're getting a fair amount of questions
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot